IOL CHEMICALS & PHARM. | CIPLA | IOL CHEMICALS & PHARM./ CIPLA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 30.2 | 45.5% | View Chart |
P/BV | x | 1.6 | 4.8 | 32.3% | View Chart |
Dividend Yield | % | 1.0 | 0.6 | 164.0% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
CIPLA Mar-23 |
IOL CHEMICALS & PHARM./ CIPLA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,185 | 45.3% | |
Low | Rs | 272 | 852 | 31.9% | |
Sales per share (Unadj.) | Rs | 377.6 | 281.9 | 134.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 35.1 | 67.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 49.7 | 63.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 8.50 | 47.1% | |
Avg Dividend yield | % | 1.0 | 0.8 | 118.5% | |
Book value per share (Unadj.) | Rs | 256.8 | 289.2 | 88.8% | |
Shares outstanding (eoy) | m | 58.71 | 807.15 | 7.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.6 | 29.6% | |
Avg P/E ratio | x | 17.1 | 29.0 | 58.9% | |
P/CF ratio (eoy) | x | 12.8 | 20.5 | 62.5% | |
Price / Book Value ratio | x | 1.6 | 3.5 | 44.7% | |
Dividend payout | % | 16.9 | 24.2 | 69.7% | |
Avg Mkt Cap | Rs m | 23,743 | 822,164 | 2.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 38,301 | 4.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 227,531 | 9.7% | |
Other income | Rs m | 256 | 5,121 | 5.0% | |
Total revenues | Rs m | 22,427 | 232,653 | 9.6% | |
Gross profit | Rs m | 2,257 | 48,079 | 4.7% | |
Depreciation | Rs m | 462 | 11,721 | 3.9% | |
Interest | Rs m | 165 | 1,095 | 15.0% | |
Profit before tax | Rs m | 1,887 | 40,384 | 4.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 12,029 | 4.1% | |
Profit after tax | Rs m | 1,391 | 28,355 | 4.9% | |
Gross profit margin | % | 10.2 | 21.1 | 48.2% | |
Effective tax rate | % | 26.2 | 29.8 | 88.1% | |
Net profit margin | % | 6.3 | 12.5 | 50.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 168,051 | 5.8% | |
Current liabilities | Rs m | 5,025 | 50,333 | 10.0% | |
Net working cap to sales | % | 20.9 | 51.7 | 40.5% | |
Current ratio | x | 1.9 | 3.3 | 57.6% | |
Inventory Days | Days | 43 | 73 | 59.1% | |
Debtors Days | Days | 8 | 7 | 127.8% | |
Net fixed assets | Rs m | 11,017 | 117,318 | 9.4% | |
Share capital | Rs m | 587 | 1,614 | 36.4% | |
"Free" reserves | Rs m | 14,490 | 231,845 | 6.2% | |
Net worth | Rs m | 15,077 | 233,460 | 6.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 290,067 | 7.1% | |
Interest coverage | x | 12.5 | 37.9 | 32.9% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.8 | 136.7% | |
Return on assets | % | 7.5 | 10.2 | 74.1% | |
Return on equity | % | 9.2 | 12.1 | 76.0% | |
Return on capital | % | 13.6 | 17.8 | 76.6% | |
Exports to sales | % | 26.7 | 22.6 | 118.1% | |
Imports to sales | % | 0 | 8.9 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 51,516 | 11.5% | |
Imports (cif) | Rs m | NA | 20,202 | 0.0% | |
Fx inflow | Rs m | 5,930 | 64,282 | 9.2% | |
Fx outflow | Rs m | 6,052 | 20,202 | 30.0% | |
Net fx | Rs m | -122 | 44,080 | -0.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 32,377 | 3.8% | |
From Investments | Rs m | -1,200 | -23,885 | 5.0% | |
From Financial Activity | Rs m | -41 | -9,583 | 0.4% | |
Net Cashflow | Rs m | -18 | -968 | 1.9% |
Indian Promoters | % | 48.2 | 13.4 | 358.8% | |
Foreign collaborators | % | 0.0 | 20.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 50.2 | 3.4% | |
FIIs | % | 1.4 | 25.8 | 5.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 66.5 | 77.9% | |
Shareholders | 130,003 | 436,154 | 29.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Cipla | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.40% | 3.79% | 1.03% |
1-Month | 6.23% | -4.95% | 1.10% |
1-Year | 1.15% | 54.91% | 53.75% |
3-Year CAGR | -12.75% | 15.82% | 14.67% |
5-Year CAGR | 16.32% | 20.10% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Cipla share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Cipla the stake stands at 33.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Cipla.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Cipla.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.